查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553598

結構生物學和分子建模技術市場規模、佔有率和趨勢分析報告：按工具、按應用、按地區、細分市場預測，2024-2030 年

Structural Biology & Molecular Modeling Techniques Market Size, Share & Trends Analysis Report By Tools (SaaS & Standalone Modeling), By Application (Drug Development), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

結構生物學和分子建模技術市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球結構生物學和分子建模技術市場規模將達到191.7億美元，2024年至2030年複合年成長率為15.4%。

不健康生活方式的不斷增加導致糖尿病和癌症等慢性病的盛行率急劇上升，預計這將在預測期內推動市場成長。

此外，據猜測，不斷增加的抗藥性和高藥物消耗率正在產生對廣泛研究和開發活動的需求，這正在推動結構生物學和分子建模技術在藥物發現和開發過程中的採用。預計這將成為加速高效藥物開發的有效方法。

對分子建模技術日益成長的需求主要是由於可以顯著節省成本。這是因為預測軟體可以透過在臨床前階段識別可能的副作用並確定藥物療效和毒性來降低後期藥物失敗的可能性。因此，上述因素是市場需求成長的重要原因。

結構生物學和分子建模技術市場報告亮點

  • 由於電腦輔助建構和建模技術在研發中的廣泛使用，到 2023 年，SaaS 和獨立建模在工具領域佔據最大佔有率。
  • 由於專注於增強藥物發現設計、旨在加速識別新療法的過程的軟體的不斷改進，藥物發現部分預計將以有利的複合年成長率成長。
  • 2023年，由於存在大量廣泛參與In Silico工具商業化並促進其利用的成熟製藥公司，北美主導了全球結構生物學和分子建模技術市場。
  • 由於政府積極支持研究活動以及新興經濟體研發外包的趨勢不斷成長，亞太地區預計將以複合年成長率大幅成長。
  • 主要參與企業正在採用臨床和研究合作策略來加速結構預測軟體和資料庫的採用，以獲得競爭優勢。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章結構生物學和分子建模技術市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 結構生物學與分子建模技術市場分析工具
    • 波特的分析
    • PESTEL分析

第4章結構生物學和分子建模技術市場：工具估計和趨勢分析

  • 細分儀表板
  • 結構生物學與分子建模技術市場：2023 年和 2030 年按工具進行的變異分析
  • SaaS 與獨立建模
  • 視覺化和分析
  • 資料庫
  • 其他

第5章結構生物學和分子建模技術市場：按應用估算和趨勢分析

  • 細分儀表板
  • 結構生物學與分子建模技術市場：2023 年和 2030 年按應用分類的變異分析
  • 藥物開發
  • 藥物發現
  • 其他

第6章結構生物學和分子建模技術市場：區域估計和趨勢分析

  • 2023 年和 2030 年結構生物學和分子建模技術市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Acellera Therapeutics Inc
    • Agilent Technologies, Inc
    • Labvantage-Biomax GmbH
    • Bruker
    • Chemical Computing Group ULC
    • Dassault Systemes
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • CD BioSciences
    • Charles River Systems, Inc.
簡介目錄
Product Code: GVR-1-68038-737-7

Structural Biology & Molecular Modeling Techniques Market Growth & Trends:

The global structural biology & molecular modeling techniques market size is expected to reach USD 19.17 billion by 2030, registering to grow at a CAGR of 15.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic diseases, such as diabetes and cancer, which is presumed to propel the market growth during the forecast period.

Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.

The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.

Structural Biology & Molecular Modeling Techniques Market Report Highlights:

  • SaaS & standalone modeling held the largest share of the tools segment in 2023 owing to extensive utilization of computer-assisted structuring and modeling techniques in R&D
  • The drug discovery segment is anticipated to grow at a lucrative CAGR owing to continual introduction of software modifications with focus on enhanced drug designing aimed to accelerate the process in identifying novel therapeutic agents
  • In 2023, North America dominated the global structural biology & molecular modeling techniques market owing to the presence of a wide number of established pharmaceutical companies extensively involved in the commercialization of in silico tools to promote their usage
  • Asia Pacific is expected to grow at an exponential CAGR owing to favorable government initiatives supporting research activities and the increasing trend of outsourcing drug development by the developed economies
  • The key participants are employing clinical and research collaborative strategies promoting the adoption of structural prediction software and databases to gain a competitive advantage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Structural Biology & Molecular Modeling Techniques Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Structural Biology & Molecular Modeling Techniques Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Structural Biology & Molecular Modeling Techniques Market: Tools Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Structural Biology & Molecular Modeling Techniques Market: Tools Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. SaaS & standalone modeling
    • 4.3.1. SaaS & Standalone Modeling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Homology Modeling
      • 4.3.2.1. Homology Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Threading
      • 4.3.3.1. Threading Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Molecular Dynamics
      • 4.3.4.1. Molecular Dynamics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Ab Initio
      • 4.3.5.1. Ab Initio Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Hybrid
      • 4.3.6.1. Hybrid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Visualization & analysis
    • 4.4.1. Visualization & analysis Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Databases
    • 4.5.1. Databases Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Structural Biology & Molecular Modeling Techniques Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Structural Biology & Molecular Modeling Techniques Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Drug Development
    • 5.3.1. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Structural Biology & Molecular Modeling Techniques Market: Regional Estimates & Trend Analysis

  • 6.1. Structural Biology & Molecular Modeling Techniques Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Acellera Therapeutics Inc
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Agilent Technologies, Inc
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Labvantage - Biomax GmbH
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Bruker
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Chemical Computing Group ULC
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Dassault Systemes
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Illumina, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Thermo Fisher Scientific Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. CD BioSciences
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Charles River Systems, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives